Leaderboard

En | De
No articles selected!     View Cart  
You are here: Oncology » Blood 30. April 2026
Search
medline.ch
Blood
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 8369  Previews Next
   
   Articles 1 - 20 / 167367  
   
Hepatosplenic T-cell Lymphoma Masquerading as Idiopathic Cytopenia.
Malays J Pathol
Raghvan HP, Wee SY, Liam CCK, Mohd Shakri N, Ho CSL, Jamian E, Subbiah I, Khalid N.
PMID: 42059175 [PubMed - indexed for MEDLINE]


A single-centre analysis of nodal peripheral T-cell lymphomas in Southern Vietnam: Insights from the WHO 2022 classification.
Malays J Pathol
Phu CD, Tieu NKN, Dang HT, Le THT, Nguyen DQA, Cao SL, Hua TNH.
PMID: 42059172 [PubMed - indexed for MEDLINE]


A model based on dynamic hematologic parameters to predict short term clinical events in pediatric acute lymphoblastic leukemia.
Turk J Med Sci
Tahta N, Gözmen S, Okur Acar S.
PMID: 42058989 [PubMed - indexed for MEDLINE]


Nontranslocation follicular lymphoma mimicking infectious mononucleosis: a diagnostic challenge in a 39-year-old male.
Oxf Med Case Reports
Barsh E, Keeling J, Pang CS, Sattler R, Feustel K, Enurah A.
PMID: 42057973 [PubMed]


CXCR4-targeted PET/CT with [¹â¸F]AlF-NOTA-QHY-04 in primary central nervous system lymphoma: a prospective comparison with MRI and [¹â¸F]FDG PET/CT.
Eur J Nucl Med Mol Imaging
Pang Y, Xing L, Liu J, Zhao X, Li C, Xu S, Pei J, Yu J, Chen H, Liu J.
PMID: 42056569 [PubMed - as supplied by publisher]


Predicting survival of Hodgkin lymphoma using machine learning-an analysis based on the SEER database.
Ann Hematol
Cai X, Kang L.
PMID: 42056487 [PubMed - indexed for MEDLINE]


Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): A practical compartment-based review.
Blood Rev
Mozas P, Combalia A, Antelo G, López-Oreja I, Castrejón de Anta N, Monge-Escartín I, Moreno-Alonso D, Gil-Lianes J, Juncosa M, Salas MQ, Charry P, Albero R, García-Herrera A, López Guillermo A, Estrach T.
PMID: 42055866 [PubMed - as supplied by publisher]


HSR26-228: BTK Inhibitor (Bruton Tyrosine Kinase Inhibitor) Plus Anti-CD20 Antibody Therapy Surpasses CIT (Chemoimmunotherapy) in Frontline CLL (Chronic Lymphocytic Leukemia) With Obinutuzumab Drives Deeper Remissions: A Meta-Analysis of Randomized Controlled Trials.
J Natl Compr Canc Netw
Sharma A, Daid SS, Sharma A, Meseeha M, Poulose J.
PMID: 42055453 [PubMed - in process]


CLO26-106: From Vasculitis to NK/T-Cell Lymphoma: A Complex Diagnosis in a Patient With a Midline Tumor and Positive ANCA.
J Natl Compr Canc Netw
Hernández I, Vargas LP, León JMM, Ballesteros-García MC, Bacca J, Ferro JD, Dorado L, Santoyo-Sarmiento N.
PMID: 42055427 [PubMed - in process]


EPR26-321: Sorafenib Plus Intensive Chemotherapy in Newly Diagnosed Adults With Acute Myeloid Leukemia: A Meta-Analysis of Randomized Controlled Trials.
J Natl Compr Canc Netw
Vatvani AD, Nada R, Altamirano MFA, Damara I, Oktrian O, Yausep OE, Shabarek N.
PMID: 42055402 [PubMed - in process]


HSR26-241: Prophylactic G-CSF (Granulocyte Colony-Stimulating Factor) in AML (Acute Myeloid Leukemia) Induction: A Meta-Analysis Dispelling Relapse Concerns and Reinforcing Supportive Benefit.
J Natl Compr Canc Netw
Sharma A, Sharma A, Daid SS, Meseeha M, Poulose J.
PMID: 42055401 [PubMed - in process]


HSR26-237: Meta-Analysis Confirms Venetoclax Plus Decitabine as a Frontline Game-Changer in Elderly AML (Acute Myeloid Leukemia).
J Natl Compr Canc Netw
Sharma A, Sharma A, Daid SS, Meseeha M, Poulose J.
PMID: 42055035 [PubMed - in process]


Random Survival Forest Versus Elastic-Net Regularized Cox Regression for Survival Prediction in Acute Myeloid Leukemia at Distinct Treatment Time Points: Model Performance Comparison Study.
JMIR Bioinform Biotechnol
Brady O, Johnson S, Giles P, Alvares C, Zabkiewicz J, Fuentes C.
PMID: 42054649 [PubMed]


Integrative Molecular Analysis Reveals Determinants of Clinical Outcomes in TP53-Mutated Diffuse Large B-Cell Lymphoma.
J Clin Oncol
Uppal M, Bhinder B, Marderstein AR, Lee Batlevi C, Falchi L, Hamlin P, Horwitz S, Kumar A, Noy A, Zelenetz AD, Lue JK, Torka P, Epstein-Peterson ZD, Arcila M, Dogan A, Imber B, Yahalom J, Vardhana SA, Intlekofer A, Raj S, Shouval R, Hodkinson B, Stokes ME, Kittai AS, Brody JD, Elemento O, Salles G, Joffe E.
PMID: 42054619 [PubMed - as supplied by publisher]


TP53 genetic alterations are highly recurrent in Epstein-Barr virus-negative aggressive NK-cell leukemia: insights from an institutional experience and comprehensive literature review.
Am J Clin Pathol
Gonzalez Mancera M, Wilk AJ, Oak J, Natkunam Y, Silva O.
PMID: 42054237 [PubMed - indexed for MEDLINE]


CD47: a promising target for immunotherapy in relapsed/refractory malignant lymphoma.
Leuk Lymphoma
Xiong S, Yue N, Zhang S, Xu Y, Cao J, Liu X, Wu C.
PMID: 42054037 [PubMed - as supplied by publisher]


Navigating Prognostic Dialogue During Serious Illness Conversations.
JAMA Netw Open
Borregaard Myrhøj C, Jacobsen J, LeBlanc TW, El-Jawahri A, Jarden M, Clemmensen SN, von Heymann A.
PMID: 42054029 [PubMed - indexed for MEDLINE]


Integrating occupational cancer detection into hospital care? An intervention research to improve blood cancer patient care in France (GISCOPE 84).
Can J Public Health
Hunsmann M, Bertschy S, Amiet É, Aubail A, Bart J, Durand C, Hamdoun F, Rat F, Richier C, Thebaud-Mony A, Zaanane H, Wolf J, Slama B, team of the Hematology-Oncology Department at Avignon Hospital, TheGISCOPE 84 Expert Panel.
PMID: 42053922 [PubMed - indexed for MEDLINE]


Evaluation of DNA methylation-based age prediction accuracy in leukemia patients using a six-CpG model trained on healthy blood.
Forensic Sci Med Pathol
Can K, Filoglu G, Ersoy G, Ozmen D, Eskazan AE, Ar MC, Bulbul O.
PMID: 42053891 [PubMed - as supplied by publisher]


Anti-CD19 chimeric antigen receptor (CAR)-T cell therapy vs. CD20xCD3 bispecific antibody as third- or later-line treatment in follicular lymphoma: a meta-analysis.
Ann Hematol
Li X, Liao J, Liu S, Mo X, Wang B.
PMID: 42053782 [PubMed - in process]


   
   Articles 1 - 20 / 167367    Page 1 of 8369  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1